Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of August 2021. The report serves to announce the results of the Company's annual general meeting of shareholders, which was held on August 10, 2021, following a one-week adjournment from the original date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance announcement rather than a financial results report.
Material Changes
No material financial changes are reported in this filing. The primary event is the shareholder approval of all proposals presented at the annual general meeting.
Guidance, Outlook, and Management Commentary
The filing confirms that shareholders approved all proposals by the requisite majority in accordance with the Israeli Companies Law and the Company's articles of association. The proposals were detailed in a Proxy Statement filed on June 23, 2021. Attendance at the meeting consisted of 8,470,114 ordinary shares, representing approximately 20.85% of the issued and outstanding ordinary shares as of the record date.
Key Facts for Investor Verification
- All shareholder proposals were approved at the annual general meeting held on August 10, 2021.
- Shareholder attendance represented approximately 20.85% of outstanding ordinary shares.
- The filing incorporates by reference into active registration statements on Form F-3 and Form S-8.
- No financial performance data is included in this specific document.